Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities
Pharmaceuticals · 20.01.2024 · 17 (1) · 136
DOI: 10.3390/ph17010136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 20.01.2024. Verfasst von Edward R Sauter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20850, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple agents derived from natural products (NPs) have been evaluated for cancer prevention and interception, either alone or in combination. The National Cancer Institute (NCI) is very interested in advancing research to identify additional agents that, alone or in combination, may prove useful in cancer prevention. Below, we provide an overview of NP studies in cancer prevention and interception, both individual agents and combination interventions. Given that findings from many preclinical studies evaluating individual agents have generally not been confirmed in human studies, our focus with individual NPs in this review is on studies involving humans, especially clinical trials. Fewer combination intervention studies have been conducted, so we have broadened our review to include preclinical studies. We conclude with how the Division of Cancer Prevention (DCP) within the NCI is providing funding to encourage the research community to propose natural product studies in cancer prevention and interception to advance the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20850, USA.
- Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD 20850, USA.
ORCID-Profile: Altaf Mohammed
Zitieren
APA
Sauter, E. R., & Mohammed, A. (2024). Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities. Pharmaceuticals, 17(1), 136. https://doi.org/10.3390/ph17010136
Vancouver
Sauter ER, Mohammed A. Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities. Pharmaceuticals. 2024;17(1):136. doi:10.3390/ph17010136
BibTeX
@article{Sauter2024,
author = {Sauter, Edward R and Mohammed, Altaf},
title = {Natural Products for Cancer Prevention and Interception: Preclinical and Clinical Studies and Funding Opportunities},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {1},
pages = {136},
doi = {10.3390/ph17010136}
}
EUVIMED